BC
ARDS

Bartlett & Co’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

Bartlett & Co’s Portfolio ARDS Stock Details ARDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$0 Buy
+150
New – ﹤0.01% 1270

Other funds holding ARDS

BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.82B AUM 15.4% 1-Year Est. Return

Bartlett & Co's ARDS Position: Q4 2023 in Review

Bartlett & Co opened a new position in Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q4 2023: 150 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1270 among its holdings.

2 funds tracked by Wall St. Rank hold ARDS as of Q4 2023.

  • Bartlett & Co held 150 shares of Aridis Pharmaceuticals Inc. Common Stock worth $0 as of Q4 2023.
  • Aridis Pharmaceuticals Inc. Common Stock was a new Bartlett & Co position in Q4 2023.
  • Aridis Pharmaceuticals Inc. Common Stock made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #1270 holding.
  • 2 funds tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.